CompletedNot Applicable

Bone Resistant Tuberculosis

France23 participantsStarted 2021-05-17

Plain-language summary

The recommendations for the treatment of MDR tuberculosis are based on pulmonary tuberculosis since there is a lack of specific recommendations for TB bone and osteoarticular disease, including those due to multi drug resistance strains (MDR IOATB). Given the lack of data regarding MDR IOATB, it may be helpful to study the diagnosis, medical treatment, surgical indications and prognosis of a cohort of MDR IOATB patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient with an MDR IOATB whose sample and / or strain has been referred to the National Reference Center (CNR) for mycobacteria in France, will be included. Exclusion Criteria: * Patient refusing to have their data used. * Patients under guardianship or curators, patients under legal protection will not be included.

What they're measuring

study of infected population with MDR TB IOATB

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT04928378

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-07-01

View on ClinicalTrials.gov More Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains trials